BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6221543)

  • 1. Syntheses of thromboxane A2 analogs: Thia- and dithiathromboxane A2.
    Hamanaka N; Ohuchida S; Hayashi M
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():319-22. PubMed ID: 6221543
    [No Abstract]   [Full Text] [Related]  

  • 2. A structural analog of thromboxane A2.
    Ansell MF; Caton MP; Palfreyman MN; Stuttle KA; Tuffin D; Walker JL
    Adv Prostaglandin Thromboxane Res; 1980; 6():485-7. PubMed ID: 7386282
    [No Abstract]   [Full Text] [Related]  

  • 3. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of thromboxane A2 analogs.
    Nicolaou KC; Magolda RL; Claremon DA
    Adv Prostaglandin Thromboxane Res; 1980; 6():481-3. PubMed ID: 6992537
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis of stable thromboxane A2 analogs: pinane thromboxane A2 (PTA2) and carbocyclic thromboxane A2 (CTA2).
    Nicolaou KC; Magolda RL
    Methods Enzymol; 1982; 86():400-9. PubMed ID: 7132765
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro and in vivo effects of new powerful thromboxane antagonists (3-alkylamino pinane derivatives).
    Katsura M; Miyamoto T; Hamanaka N; Kondo K; Terada T; Ohgaki Y; Kawasaki A; Tsuboshima M
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():351-7. PubMed ID: 6221545
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of human platelet thromboxane synthetase by 11a-carbathromboxane A2 analogs.
    Gorman RR; Maxey KM; Bundy GL
    Biochem Biophys Res Commun; 1981 May; 100(1):184-90. PubMed ID: 7196228
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostaglandin endoperoxide and thromboxane A2 analogs.
    Wilson NH; Jones RL
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 14():393-425. PubMed ID: 2992245
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation.
    Nicolaou KC; Magolda RL; Smith JB; Aharony D; Smith EF; Lefer AM
    Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2566-70. PubMed ID: 288046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aza-substituted omega-side-chain modifications of 7-oxabicyclo[2.2.1]heptane thromboxane A2 receptor antagonists: structure-activity relationships.
    Nakane M; Reid JA; Haslanger MF; Garber DP; Harris DN; Ogletree ML; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():291-3. PubMed ID: 3004140
    [No Abstract]   [Full Text] [Related]  

  • 11. Developments of TXA2 antagonists.
    Hamanaka N
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():663-5. PubMed ID: 2526556
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
    Shaw LA; Batey AJ; Coker SJ
    Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prostaglandins and thromboxane A2 on the contractility of rabbit splenic capsular smooth muscle.
    Peskar BA; Förstermann U; Simmet T
    Artery; 1980; 8(1):1-6. PubMed ID: 7000038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pinane thromboxane A2: a TXA2 antagonist with antithrombotic properties.
    Aharony D; Smith JB; Smith EF; Lefer AM; Magolda RL; Nicolaou KD
    Adv Prostaglandin Thromboxane Res; 1980; 6():489-92. PubMed ID: 6992538
    [No Abstract]   [Full Text] [Related]  

  • 15. Biological effects of 15-hydroperoxythromboxane A2 on platelets and aorta.
    Hammarström S
    Prostaglandins Med; 1980 May; 4(5):297-302. PubMed ID: 7403329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the influence of nitroglycerin on the synthesis of prostaglandins and thromboxane A2 and on platelet aggregation.
    Rettkowski W; Pönicke K; Block HU; Giessler C; Dunemann A; Zehl U; Förster W
    Arzneimittelforschung; 1982; 32(3):194-200. PubMed ID: 6805480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane A2 biosynthesis in the ureter obstructed isolated perfused kidney of the rabbit.
    Morrison AR; Nishikawa K; Needleman P
    J Pharmacol Exp Ther; 1978 Apr; 205(1):1-8. PubMed ID: 633076
    [No Abstract]   [Full Text] [Related]  

  • 18. Syntheses and biological activities of some prostacyclin analogs.
    Ohuchida S; Hashimoto S; Wakatsuka H; Arai Y; Hayashi M
    Adv Prostaglandin Thromboxane Res; 1980; 6():337-40. PubMed ID: 6992532
    [No Abstract]   [Full Text] [Related]  

  • 19. Heparin potentiates synthesis of thromboxane A2 in human platelets.
    Anderson WH; Mohammad SF; Chuang HY; Mason RG
    Adv Prostaglandin Thromboxane Res; 1980; 6():287-91. PubMed ID: 7386269
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of thromboxane antagonist EP 045 on platelet aggregation.
    Jones RL; Wilson NH; Armstrong RA; Peesapati V; Smith GM
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():345-50. PubMed ID: 6303074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.